Junya Toguchida, MD, PhD
Junya Toguchida, MD, PhD, is a Professor at the Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan. He is also a clinical professor of the Department of Orthopaedic Surgery, Kyoto University Hospital in Kyoto. Dr. Toguchida received a medical degree from Kyoto University. After completing the residency as an orthopedic surgeon and obtaining a doctorate of Medical Science from the Graduate School of Medicine, Kyoto University, he carried out a postdoctoral fellowship at the Massachusetts Eye & Ear Infirmary, Harvard University, Boston. In 1995, Dr. Toguchida became an associate professor in the Institute for Frontier Medicine, Kyoto University and also joined the staff in the Department of Orphopaedic Surgery, Kyoto University Hospital as a chief surgeon in the filed of Orthopedic Oncology. He was promoted to be a full professor of the Department of Tissue Regeneration in the Institute for Frontier Medicine since 2004.
Dr. Toguchida’s research interests center on clinical and biological research in the field of bone and soft tissue sarcomas, as well as tissue regeneration therapy for musculoskeletal disorders. He is currently performing a clinical application of mesenchymal stem cells for the treatment of extensive bone defects due to sarcomas. He is also managing the sarcoma tissue bank for the multi-institutional scientific study in Japan.
He is a contributor of more than 80 articles published in peer-reviewed journals such as Nature, New England Journal of Medicine, Cancer Research, Journal of National Cancer Institute, and Oncogene. He addresses a range of subjects that includes the role of tumor suppressor genes in sarcomas of bone and soft tissues, and the molecular profiling of sarcomas for the diagnosis and the development of molecular target therapy.
Dr. Toguchida is active in numerous professional organizations, most prominently Connective Tissue Oncology Society (CTOS), of which he was president in 2006. He is a board member of the Japanese Orthopedic Association, Japanese Clinical Cancer Association, Japanese Society of Tissue Engineering, and an active member of the American Association for Cancer Research (AACR), Societe Internationale de Chirurgie et de Traumatologie (SICOT), and Japanese Cancer Association.
Copyright © 2012 Liddy Shriver Sarcoma Initiative.